Reverse left ventricular remodeling after aortic valve replacement for aortic stenosis: a systematic review and meta-analysis

Data de publicação:

Autores da FMUP

  • Bernardo Manuel De Sousa Pinto

    Autor

  • Francisca Almeida Saraiva

    Autor

  • Joaquim Adelino Correia Ferreira Leite Moreira

    Autor

Participantes de fora da FMUP

  • Sousa Nunes F.
  • Amaral Marques C.
  • Isabel Pinho A.
  • Beco A.
  • Ricardo Silva J.
  • Macedo F.
  • Sousa C.

Unidades de investigação

Abstract

Reverse left ventricular (LV) remodeling after aortic valve replacement (AVR), in patients with aortic stenosis, is well-documented as an important prognostic factor. With this systematic review and meta-analysis, we aimed to characterize the response of the unloaded LV after AVR. We searched on MEDLINE/PubMed and Web of Science for studies reporting echocardiographic findings before and at least 1 month after AVR for the treatment of aortic stenosis. In total, 1,836 studies were identified and 1,098 were screened for inclusion. The main factors of interest were structural and dynamic measures of the LV and aortic valve. We performed a random-effects meta-analysis to compute standardized mean differences (SMD) between follow-up and baseline values for each outcome. Twenty-seven studies met the eligibility criteria, yielding 11,751 patients. AVR resulted in reduced mean aortic gradient (SMD: (Formula presented.) mmHg, 95% CI: (Formula presented.) to (Formula presented.), (Formula presented.)), LV mass (SMD: (Formula presented.) g, 95% CI: (Formula presented.) to (Formula presented.), (Formula presented.)), end-diastolic LV diameter (SMD: (Formula presented.) mm, 95% CI: (Formula presented.) to (Formula presented.), (Formula presented.)), end-diastolic LV volume (SMD: (Formula presented.) ml, 95% CI: (Formula presented.) to 3.51, (Formula presented.)), increased effective aortic valve area (SMD: 1.10 cm2, 95% CI: 1.01 to 1.20, (Formula presented.)), and LV ejection fraction (SMD: 2.35%, 95% CI: 1.31 to 3.40%, (Formula presented.)). Our results characterize the extent to which reverse remodeling is expected to occur after AVR. Notably, in our study, reverse remodeling was documented as soon as 1 month after AVR. 2024 Sousa Nunes, Amaral Marques, Isabel Pinho, Sousa-Pinto, Beco, Ricardo Silva, Saraiva, Macedo, Leite-Moreira and Sousa.

Dados da publicação

ISSN/ISSNe:
2297-055X, 2297-055X

Frontiers in Cardiovascular Medicine  Frontiers Media S.A.

Tipo:
Review
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • aortic stenosis; aortic valve; aortic valve replacement; body surface; diabetes mellitus; echocardiography; follow up; heart left ventricle; heart left ventricle ejection fraction; heart left ventricle enddiastolic volume; heart left ventricle mass; heart ventricle remodeling; human; hypertension; ischemic heart disease; left ventricular end-diastolic diameter; maximum likelihood method; meta analysis; New York Heart Association class; outcome assessment; quality control; Review; risk assessment; systematic review; transcatheter aortic valve implantation; univariate analysis

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy Trial (STICH 3C) - NCT05427370

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Ensaio Clínico Académico (STICH 3C) . Cornell University . 2023

Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023

Estudo do tratamento da doença valvular aórtica.

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Observacional Académico (AORTA) . UniC . 2019

Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Ensaio Clínico Académico (Ensaio AGTP II) . 2019

Aortic valve surgery with stented versus stentless bioprosthesis in patients with active infective endocarditis

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Endocarditis) . 2023

Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Bypass) . 2020

Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Aortic Valve Replacemen) . 2020

Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2021

Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers

Investigador Principal: Bernardo Manuel De Sousa Pinto

Estudo Clínico Académico (SARS-CoV-2) . 2021

"Aortic valve surgery in patients with infective endocarditis: mid-term follow-up of patients treated with the St. Jude medical trifecta™ valve"

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2022

Long-term survival after coronary artery bypass grafting: the relevance of surgical procedures analysed by propensity score methods.

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Arrtery bypass) . 2022

Abdominal Aortic Aneurysm - The Portuguese Case: Specificities and Consequences

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2022

New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2021

Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2020

Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação